Paper33208917
Mechanisms and therapeutic implications of cellular senescence in osteoarthritis.
Coryell PR and 2 others. Nat Rev Rheumatol, 2021. Cited by 640 papers, by iCite.
Cite this record
ConductScience Library. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Papers, record 33208917. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33208917
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Review
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cartilage, Articular | Major topic |
| Cellular Senescence | Major topic |
| Chondrocytes | Major topic |
| Osteoarthritis | Major topic |
| Ageism | |
| Aging | |
| Animals | |
| Antibodies, Monoclonal, Humanized | |
| Biomarkers | |
| Clinical Trials as Topic | |
| DNA Damage | |
| Disease Progression | |
| Humans | |
| Hypolipidemic Agents | |
| Mice | |
| Models, Animal | |
| Oxidative Stress | |
| Phenotype | |
| Protein Kinase Inhibitors | |
| TOR Serine-Threonine Kinases |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AG044034 | NIA NIH HHS | United States | R01AG044034 | PubMed and NIH | NIH RePORTER |
| R37 AR049003 | NIAMS NIH HHS | United States | R37AR049003 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05637216 | Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients | Background |
Source ClinicalTrials.gov
References126
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23140366 | Aging, cellular senescence, and cancer. | Annu Rev Physiol | 2013 | https://conductscience.org/library/papers/23140366 | PubMed |
| 2 | 20506158 | Cartilage cell clusters. | Arthritis Rheum | 2010 | https://conductscience.org/library/papers/20506158 | PubMed |
| 3 | 31285188 | Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy. | EBioMedicine | 2019 | https://conductscience.org/library/papers/31285188 | PubMed |
| 4 | 22882466 | Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. | Aging Cell | 2012 | https://conductscience.org/library/papers/22882466 | PubMed |
| 5 | 31838837 | Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases. | Mol Cells | 2019 | https://conductscience.org/library/papers/31838837 | PubMed |
| 6 | 31408372 | Controlled induction and targeted elimination of p16INK4a-expressing chondrocytes in cartilage explant culture. | FASEB J | 2019 | https://conductscience.org/library/papers/31408372 | PubMed |
| 7 | 27341653 | Identification of Senescent Cells in the Bone Microenvironment. | J Bone Miner Res | 2016 | https://conductscience.org/library/papers/27341653 | PubMed |
| 8 | 28213268 | Fisetin inhibits IL-1β-induced inflammatory response in human osteoarthritis chondrocytes through activating SIRT1 and attenuates the progression of osteoarthritis in mice. | Int Immunopharmacol | 2017 | https://conductscience.org/library/papers/28213268 | PubMed |
| 9 | 30653843 | A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis. | Arthritis Rheumatol | 2019 | https://conductscience.org/library/papers/30653843 | PubMed |
| 10 | 20010931 | Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. | Nat Protoc | 2009 | https://conductscience.org/library/papers/20010931 | PubMed |
| 11 | 26147250 | MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. | Nat Cell Biol | 2015 | https://conductscience.org/library/papers/26147250 | PubMed |
| 12 | 31568766 | Replicative senescence is distinguishable from DNA damage-induced senescence by increased methylation of promoter of rDNA and reduced expression of rRNA. | Mech Ageing Dev | 2019 | https://conductscience.org/library/papers/31568766 | PubMed |
| 13 | 28575665 | Senescence in Health and Disease. | Cell | 2017 | https://conductscience.org/library/papers/28575665 | PubMed |
| 14 | 20078217 | The senescence-associated secretory phenotype: the dark side of tumor suppression. | Annu Rev Pathol | 2010 | https://conductscience.org/library/papers/20078217 | PubMed |
| 15 | 21093253 | Cellular senescence: putting the paradoxes in perspective. | Curr Opin Genet Dev | 2011 | https://conductscience.org/library/papers/21093253 | PubMed |
| 16 | 23746838 | The hallmarks of aging. | Cell | 2013 | https://conductscience.org/library/papers/23746838 | PubMed |
| 17 | 14702177 | Interleukin-1beta-induced expression of the urokinase-type plasminogen activator receptor and its co-localization with MMPs in human articular chondrocytes. | Histol Histopathol | 2004 | https://conductscience.org/library/papers/14702177 | PubMed |
| 18 | 18358926 | Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. | Lancet | 2008 | https://conductscience.org/library/papers/18358926 | PubMed |
| 19 | 24416650 | IL-6-STAT3 signaling and premature senescence. | JAKSTAT | 2013 | https://conductscience.org/library/papers/24416650 | PubMed |
| 20 | 29744983 | Expression of p16INK4a is a biomarker of chondrocyte aging but does not cause osteoarthritis. | Aging Cell | 2018 | https://conductscience.org/library/papers/29744983 | PubMed |
Cited by445
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 640 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983527 | Donor-tailored MSC-EVs for osteoarthritis phenotypes: source heterogeneity, engineering, and precision therapy. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42983527 | PubMed |
| 42957763 | The gut-muscle-joint axis in osteoarthritis: Mechanistic insights and therapeutic perspectives. | Eur J Clin Nutr | 2026 | https://conductscience.org/library/papers/42957763 | PubMed |
| 42942738 | Barrier-Guided Local Nanopharmaceutics for Cartilage and Osteochondral Regeneration: From Effective Tissue Exposure to Cell-State Control and Translational Quality Attributes. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942738 | PubMed |
| 42940141 | Serum Sphingomyelin and Osteoarthritis Risk: Evidence from Mendelian Randomization, Genetic Colocalization, and a Rat Model. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940141 | PubMed |
| 42920818 | Mechanoinflammation in osteoarthritis: knowledge evolution, cellular interactions, and translational research priorities. | Front Immunol | 2026 | https://conductscience.org/library/papers/42920818 | PubMed |
| 42902180 | Periplocin targets low density lipoprotein receptor-related protein 4 and protects against osteoarthritis. | Cell Mol Biol Lett | 2026 | https://conductscience.org/library/papers/42902180 | PubMed |
| 42875857 | Mitochondrial Quality Control in Degenerative Musculoskeletal Diseases: Signaling Networks and Therapeutic Landscapes. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42875857 | PubMed |
| 42875481 | Emerging therapies for knee osteoarthritis. | Nat Rev Rheumatol | 2026 | https://conductscience.org/library/papers/42875481 | PubMed |
| 42864749 | A Dual-Functional Nanoplatform Targeting the dsDNA-cGAS Axis to Mitigate Disc Degeneration and Aberrant Innervation. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42864749 | PubMed |
| 42858303 | M2 Macrophage-Derived Small Extracellular Vesicle miR-106a-Loaded QCG Hydrogel Targets the RNF128-LXR Pathway to Reprogram Chondrocyte Cholesterol Metabolism for Osteoarthritis Therapy. | J Extracell Vesicles | 2026 | https://conductscience.org/library/papers/42858303 | PubMed |
| 42857536 | Immune-metabolic convergence in skeletal remodeling disorders: shared osteoimmune, senescent and lipid mechanisms across aging-related and immune-mediated bone disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42857536 | PubMed |
| 42830759 | Exercise alleviates age-related osteoarthritis associated with PGC-1α activation to suppress chondrocyte senescence and aberrant glycolysis. | J Orthop Translat | 2026 | https://conductscience.org/library/papers/42830759 | PubMed |
| 42799503 | Integrative identification and preliminary validation of senescence-associated secretory phenotype-related candidate biomarkers in type 2 diabetes. | PeerJ | 2026 | https://conductscience.org/library/papers/42799503 | PubMed |
| 42792121 | Comparative Phytochemical Profiling, Antioxidant Activity, and Chondrocyte Cytocompatibility of Water and Ethanolic Extracts from Different Organs of Golden Gardenia (Gardinia sootepensis). | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42792121 | PubMed |
| 42746594 | "Gut-Joint Axis" Perspective on Immunometabolic Crosstalk in Osteoarthritis: A Narrative Review of Mechanistic Insights and Targeted Strategies. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42746594 | PubMed |
| 42707686 | Harnessing Natural Extracellular Vesicles to Combat Age-Related Diseases: From Aging Drivers to Therapeutic Opportunities. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42707686 | PubMed |
| 42662120 | From mechanical adaptation to innate immune reprogramming in osteoarthritis: a load-immunity framework. | Front Immunol | 2026 | https://conductscience.org/library/papers/42662120 | PubMed |
| 42653464 | From Joint Loading to Osteoarthritis: A Multiscale Review of Knee Mechanobiology and Digital Modelling. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653464 | PubMed |
| 42581264 | A Review of Rejuvenation Strategies Targeting Mesenchymal Stem Cell Senescence and Their Impact on Bone Health and Regeneration. | Curr Osteoporos Rep | 2026 | https://conductscience.org/library/papers/42581264 | PubMed |
| 42577500 | New therapeutic target for osteoarthritis: modulating immune-metabolic aberrations and micromilieu remodeling in underlying bone. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42577500 | PubMed |
Genes26
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33208917
GET https://conductscience.org/api/papers/v1/33208917/references?page=2